Spain: Strategies for plant protection

Managing IP is part of Legal Benchmarking Limited, 1-2 Paris Gardens, London, SE1 8ND

Copyright © Legal Benchmarking Limited and its affiliated companies 2025

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

Spain: Strategies for plant protection

The tension in the relationship between patent rights and plant breeder's rights (PBR) is widely known. Recently, some EU member states have opposed the decision taken by the Enlarged Board of Appeals of the European Patent Office (EPO) in cases G2/12 and G2/13 .

G2/12 and G2/13 concluded that plants obtained by an essentially biological process, excluded from patentability according to Article 53(b) EPC, are not excluded from patentability, but in December 2016 the EPO decided to stay all proceedings in examination and opposition cases in which the invention was a plant or animal obtained by an essentially biological process. This decision was taken following the discussion on the recent Notice of the European Commission related to the exclusion from patentability of said plants interpreted from the Biopatent Directive (98/44/EC) and supported by Spain jointly with Austria, Belgium, the Czech Republic, Denmark, France, Germany, Greece, the Netherlands, Norway, Poland, Portugal, Romania and Switzerland.

If finally the EPO follows the interpretation offered by the European Commission Notice, PBRs would be the main route of the protection of plants derived from essentially biological processes.

In order to obtain PBRs, the plant material must be novel, distinct, stable and homogeneous, but also it must be assigned a valid variety denomination. Since time elapsed between the application date and the grant of PBRs, it is advisable to protect this denomination simultaneously as a trade mark but taking into account proceeding of the Guidelines established by the Community and national regulations. At European Community level, at the time the PBR is granted, the trade mark will be annulled since the variety denomination would be generic. Nevertheless, the breeder would have the exclusive right to prevent third parties with an identical or similar denomination during this period. At national level, in Spain, according to the Article 48.4 of the Law No 3/2000, the applicant must undertake to waive the Spanish trade mark rights at the time the PBR is granted.

It is also remarkable that, according to article 19 of the Spanish Regulation (Real Decreto) No 1261/2005 which approves the regulation of protection of plant varieties, it is necessary to register in the corresponding Spanish Ministry a Community plant variety licence contract to ensure that infringements of the corresponding national PBRs are equally applicable to infringements of the Community PBRs. From 2005, the licences of exploitation of PBRs have shown a clear and surprising upward movement, indicating that the PBRs generated by the breeding sector are growing strongly in this country.

Rafa Lopez

Esther Rubio


PONS IPGlorieta Rubén Darío, 428010 – Madrid SpainTel: +34 917007600Fax: +34 913086103clientes@pons.eswww.ponsip.com

more from across site and SHARED ros bottom lb

More from across our site

Niri Shan, the newly appointed head of IP for UK, Ireland and the Middle East, explains why the firm’s international setup has brought UPC success, and addresses German partner departures
Vlad Stanese joins our ‘Five minutes with’ series to discuss potentially precedent-setting trademark and copyright cases and his love for aviation
Heath Hoglund, president of Via LA, discusses how it sets royalty rates and its plans to build on growth in China
Stobbs stands accused of interfering with the administration of justice after Brandsmiths’ client was subjected to an interim injunction for unjustified threats
The firm, known for its prosecution expertise, discusses its plans following the appointment of a UK-based patent litigation head and two new partners
Ed White at Clarivate provides an exclusive insight into the innovation power clusters reshaping Europe and the Middle East’s IP landscape, and why quality is the new currency of invention
In the first in a new podcast series celebrating the tenth anniversary of IP Inclusive, we look back at the network’s origins and discuss its mission
Rebecca Schwarz at Haynes Boone shares how her team secured victory for biopharma client RedHill in a licensing dispute involving a developmental cancer drug
News of a breakaway firm launching in Germany and a spike in vaccine-related patent applications were also among the top talking points
A flurry of hiring activity among UK firms suggests they are confident of mounting a serious challenge at the UPC
Gift this article